Because of the anti-inflammatory effects of VIP, we speculate that the high VIP content in PD patients who are not accompanied by depression and anxiety symptoms may reduce the release of pro-inflammatory mediators by activated microglia through these effects, thereby reducing the occurrence of mood disorders. The gene discussed is VIP; the disease is mood disorder.